Our study underscores the importance of intensified post-HTx monitoring foryoung DCM patients who present with elevated baseline levels of NT-proBNP and UA,along with a reduction in LVEF within the 2 years prior to HTx. This evidence concerns the gene NPPB and familial dilated cardiomyopathy.